OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on TechCrunch.